| Dr John Newton Clore, MD | |
|
125 Nationwide Dr, Internal Medicine, Lynchburg, VA 24502-4272 | |
| (434) 200-3908 | |
| Not Available |
| Full Name | Dr John Newton Clore |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 39 Years |
| Location | 125 Nationwide Dr, Lynchburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023108669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101035645 (Virginia) | Secondary |
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101035645 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Memorial Regional Medical Center | Mechanicsville, VA | Hospital |
| Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Richmond Specialty Care Llc | 8022440056 | 260 |
News Archive
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
Consumers will choose and eat more indulgent food after they see someone who is overweight-unless they consciously think about their health goals, according to a new study in the Journal of Consumer Research.
Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
To improve care for patients with kidney dysfunction, investigators are striving to identify modifiable risk factors that may slow the progression of chronic kidney disease (CKD) to kidney failure.
› Verified 3 days ago
| Entity Name | Bon Secours Memorial Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881795557 PECOS PAC ID: 6507775293 Enrollment ID: O20040726000687 |
News Archive
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
Consumers will choose and eat more indulgent food after they see someone who is overweight-unless they consciously think about their health goals, according to a new study in the Journal of Consumer Research.
Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
To improve care for patients with kidney dysfunction, investigators are striving to identify modifiable risk factors that may slow the progression of chronic kidney disease (CKD) to kidney failure.
› Verified 3 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
Consumers will choose and eat more indulgent food after they see someone who is overweight-unless they consciously think about their health goals, according to a new study in the Journal of Consumer Research.
Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
To improve care for patients with kidney dysfunction, investigators are striving to identify modifiable risk factors that may slow the progression of chronic kidney disease (CKD) to kidney failure.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Newton Clore, MD 2010 Atherholt Rd, Lynchburg, VA 24501-1106 Ph: () - | Dr John Newton Clore, MD 125 Nationwide Dr, Internal Medicine, Lynchburg, VA 24502-4272 Ph: (434) 200-3908 |
News Archive
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
Consumers will choose and eat more indulgent food after they see someone who is overweight-unless they consciously think about their health goals, according to a new study in the Journal of Consumer Research.
Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
To improve care for patients with kidney dysfunction, investigators are striving to identify modifiable risk factors that may slow the progression of chronic kidney disease (CKD) to kidney failure.
› Verified 3 days ago
Varsha Reddy Pothula Venkata, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 103 Clifton St, Lynchburg, VA 24501 Phone: 434-455-7100 Fax: 434-947-5909 | |
Dr. James D Cure, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1901 Thomson Dr, Lynchburg, VA 24501 Phone: 434-947-3908 Fax: 434-947-5948 | |
Edward Vincent Bonyak, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-5252 Fax: 434-200-5252 | |
Sally- Ann Tracy Mcintosh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2215 Landover Pl, Lynchburg, VA 24501 Phone: 434-947-3944 Fax: 866-617-8273 | |
Dr. Evan D. Ownby, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-2712 Fax: 434-200-2851 | |
Dr. Samuel Omotoye, M.D., FRCPC Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-2712 Fax: 434-200-2851 |